Key result
MRI atrial substrate score strongly predicts post-cryoballoon PVI arrhythmia recurrence with ~0.96 AUC.
Why the study?
Conventional classification of AF as paroxysmal or persistent may not reflect structural atrial remodeling and has limited value for predicting recurrence after PVI. This study evaluated whether an MRI-derived substrate score combining LA fibrosis and size improves recurrence risk stratification after first-time cryoballoon PVI.
Does an MRI-derived atrial substrate score combining left atrial fibrosis and size improve prediction of 12-month arrhythmia recurrence compared to conventional AF phenotype in patients undergoing first-time cryoballoon pulmonary vein isolation?
Observational (n=69)
Does an MRI-derived atrial substrate score combining left atrial fibrosis and size improve prediction of 12-month arrhythmia recurrence compared to conventional AF phenotype in patients undergoing first-time cryoballoon pulmonary vein isolation?
Answers are grounded in this paper and cite their sources.
An MRI-derived substrate score combining left atrial size and fibrosis strongly predicts 12-month arrhythmia recurrence after first-time cryoballoon pulmonary vein isolation, outperforming conventional paroxysmal versus persistent AF classification.
BACKGROUND AND AIMS: The conventional classification of atrial fibrillation (AF) as paroxysmal or persistent may not reflect structural atrial remodeling and has limited value for predicting recurrence after pulmonary vein isolation (PVI). We investigated whether an MRI-derived substrate score combining left atrial (LA) fibrosis and size improves recurrence risk stratification after first-time cryoballoon PVI. METHODS: We retrospectively analyzed 69 patients undergoing first cryoballoon PVI; 67 underwent pre-procedural 3-Tesla late gadolinium enhancement MRI. LA fibrosis was graded using the UTAH classification; the maximal horizontal LA diameter in the two-chamber view was measured, and LA volume was calculated with a 3D tool. An exploratory point-based score was constructed from LA diameter categories (< 44 mm, 0 points; 44-< 48 mm, 2 points; ≥ 48 mm, 4 points) and advanced fibrosis (UTAH stage 3-4, 1 point). Discrimination for 12-month arrhythmia recurrence was assessed by ROC analysis. RESULTS: Advanced fibrosis was present in half of the patients with paroxysmal AF, with a similar UTAH distribution in both phenotypes (p = 0.83). LA diameter and volume were larger in patients with recurrence and discriminated recurrence (AUC 0.95 and 0.92). The substrate score predicted recurrence (AUC 0.96, 95% CI 0.91-0.99), with recurrence rates of 0%, 41% and 96% in low-, intermediate- and high-risk patients. LA size was the main contributor, with fibrosis providing complementary information, whereas AF phenotype did not provide incremental predictive value. CONCLUSIONS: An MRI-derived substrate score, with LA size as the main contributor and fibrosis as a complementary marker, predicted arrhythmia recurrence after cryoballoon PVI better than the conventional AF phenotype. External validation is required before clinical implementation.
No takes yet. Share an insight, caveat, or question.
Koektuerk et al. (2026) conducted an observational in Atrial fibrillation undergoing first-time cryoballoon pulmonary vein isolation (n=69). MRI-derived atrial substrate score (combining LA diameter and UTAH fibrosis stage) vs. Conventional AF phenotype (paroxysmal vs. persistent) was evaluated on 12-month arrhythmia recurrence (AUC 0.96, 95% CI 0.91-0.99). An MRI-derived atrial substrate score combining LA size and fibrosis predicted 12-month arrhythmia recurrence after cryoballoon PVI.
Synapse has enriched 10 related papers. Consider them for comparative context: